Anna Feliu

TL;DR: A sharp decrease in HCV viral load occurs during the anhepatic phase and immediately after graft reperfusion, most likely owing to a lack of virion production and hepatic viral clearance.

TL;DR: The data support the utilization of antiviral therapy in HCV-infected patients awaiting LT as one of the strategies to prevent hepatitis C recurrence after transplantation.

TL;DR: The results were based on a single‐center experience and should be considered in the decision‐making process of transplant programs, since severe HCV recurrence may ultimately compromise graft and patient survival.

TL;DR: A first quantitative picture of the extrahepatic hepatitis C viral contribution is provided and may suggest new approaches for viral clearance.

TL;DR: HCV nosocomial infection appears to occur via patient‐to‐patient transmission in liver units, particularly in individuals who require long hospitalizations, and continuous reinforcement of universal prevention measures and, when possible, isolation of patients at higher risk might further reduce Nosocomial HCV transmission.